- Home
- AENT vs STXS Comparison
AENT vs STXS Comparison
Compare AENT & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AENT
- STXS
- Stock Information
- Founded
- AENT 1990
- STXS 1990
- Country
- AENT United States
- STXS United States
- Employees
- AENT N/A
- STXS N/A
- Industry
- AENT Durable Goods
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AENT Consumer Discretionary
- STXS Health Care
- Exchange
- AENT Nasdaq
- STXS Nasdaq
- Market Cap
- AENT 161.5M
- STXS 151.3M
- IPO Year
- AENT N/A
- STXS 2004
- Fundamental
- Price
- AENT $4.24
- STXS $2.12
- Analyst Decision
- AENT Strong Buy
- STXS
- Analyst Count
- AENT 1
- STXS 0
- Target Price
- AENT $10.00
- STXS N/A
- AVG Volume (30 Days)
- AENT 38.5K
- STXS 282.1K
- Earning Date
- AENT 05-15-2025
- STXS 08-11-2025
- Dividend Yield
- AENT N/A
- STXS N/A
- EPS Growth
- AENT N/A
- STXS N/A
- EPS
- AENT 0.23
- STXS N/A
- Revenue
- AENT $1,072,641,000.00
- STXS $27,510,000.00
- Revenue This Year
- AENT $4.77
- STXS $25.90
- Revenue Next Year
- AENT N/A
- STXS $60.57
- P/E Ratio
- AENT $16.40
- STXS N/A
- Revenue Growth
- AENT N/A
- STXS 1.50
- 52 Week Low
- AENT $1.10
- STXS $1.54
- 52 Week High
- AENT $11.57
- STXS $2.72
- Technical
- Relative Strength Index (RSI)
- AENT 68.06
- STXS 47.30
- Support Level
- AENT $3.70
- STXS $2.00
- Resistance Level
- AENT $4.33
- STXS $2.36
- Average True Range (ATR)
- AENT 0.30
- STXS 0.13
- MACD
- AENT 0.07
- STXS -0.01
- Stochastic Oscillator
- AENT 75.00
- STXS 31.58
About AENT Alliance Entertainment Holding Corporation
Alliance Entertainment Holding Corp is a top-tier distributor of music, movies, and consumer electronics. It offers products consisting of vinyl records, compact discs, DVDs, Blu-rays, and video games. The company serves customers of every size, providing a suite of services to resellers and retailers around the world.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.